Viewing Study NCT05270057


Ignite Creation Date: 2025-12-24 @ 7:03 PM
Ignite Modification Date: 2025-12-29 @ 5:45 PM
Study NCT ID: NCT05270057
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-10-09
First Post: 2022-02-24
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Loncastuximab Tesirine in Combination With DA-EPOCH-R in Patients With Previously Untreated Aggressive B-cell Lymphoid Malignancies
Sponsor:
Organization: